EC Approves Frontline Lung Cancer Combo EC Approves Frontline Lung Cancer Combo

The European Commission (EC) has approved the combination of pembrolizumab, pemetrexed, and platinum chemotherapy for the first-line treatment of metastatic non – small cell lung cancer.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news